Clinical trials
Alzheimer Disease trials in Greece
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
36 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2005 | 1 |
| 2006 | 1 |
| 2007 | 4 |
| 2008 | 2 |
| 2012 | 3 |
| 2013 | 2 |
| 2014 | 1 |
| 2016 | 4 |
| 2019 | 2 |
| 2020 | 1 |
| 2021 | 3 |
| 2022 | 2 |
| 2024 | 1 |
| 2025 | 7 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 15 |
| Recruiting | 9 |
| Terminated | 7 |
| Unknown status | 3 |
| Active, not recruiting | 1 |
| Enrolling by invitation | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| GlaxoSmithKline | 6 |
| Aristotle University Of Thessaloniki | 4 |
| Bristol-Myers Squibb | 4 |
| AbbVie (prior sponsor, Abbott) | 2 |
| Eidos Therapeutics, a BridgeBio company | 2 |
| AB Science | 1 |
| Altoida | 1 |
| Boehringer Ingelheim | 1 |
| Eisai Co., Ltd. | 1 |
| Elpen Pharmaceutical Co. Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Alzheimer Disease | 36 |
| Cognitive Dysfunction | 9 |
| Dementia | 8 |
| Amyloidosis | 3 |
| Memory Disorders | 3 |
| Amyloid Neuropathies, Familial | 2 |
| Cardiomyopathies | 2 |
| Heart Diseases | 2 |
| Psychomotor Agitation | 2 |
| Asymptomatic Diseases | 1 |
Trials
Showing 26 to 36 of 36. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.